Columbia University
1,580
226
299
951
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
14.2%
224 terminated/withdrawn out of 1580 trials
80.9%
-5.6% vs industry average
10%
161 trials in Phase 3/4
46%
438 of 951 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (1580)
Decellularized Human Placental Extracellular Matrix Tissue for Rotator Cuff Repair Augmentation
Role: lead
DELINEATE-Prospective
Role: lead
FITting Non-invasive Tests in Lynch Syndrome Surveillance
Role: collaborator
Glycemic Observation and Metabolic Outcomes in Mothers and Offspring
Role: collaborator
rTMS for Postoperative Brain Tumor Patients
Role: collaborator
A Study of Combination Spartalizumab and Canakinumab in Patients With Localized Clear Cell Renal Cell Carcinoma
Role: lead
The SCOPE Trial: Sleep, Cognition, and Pain Bundle vs. ERAS-cardiac for Postoperative Delirium
Role: collaborator
Patient Perspectives Medicaid Title XIX Sterilization Consent Form
Role: lead
The Sleep2BWell Trial
Role: lead
Kidney Precision Medicine Project
Role: collaborator
CNGB1 and Allied Disorders
Role: lead
Mast Cell Treatment in Post-tick Bite Illness (PTBI)
Role: collaborator
MyHand 2: An Active Hand Orthosis for Stroke Patients
Role: lead
Accelerated Age-related Cognitive Decline: Impact of Exercise on Executive Function and Neuroplasticity
Role: lead
Low and High Flow Suctioning in Intubated Infants
Role: lead
Evaluation of the Asthma Management Program to Promote Activity for Students in Schools (Asthma-PASS)
Role: collaborator
Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health
Role: lead
Human Models of Selective Insulin Resistance: Alpelisib, Part I
Role: lead
Discogen for Low Back Pain
Role: lead
Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders
Role: lead